In the January 2025 presentation, Jazz Pharmaceuticals expects zanidatamab to potentially receive approval and be launched as ...
In November 2025, Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology firm specializing in therapies for primary ...
Glaciers are flush with microbial life. But, as climate change speeds glacial melting, scientists rush to establish microbial ...